These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2909912)

  • 1. CSF acetylcholinesterase levels are reduced in multiple system atrophy with autonomic failure.
    Polinsky RJ; Holmes KV; Brown RT; Weise V
    Neurology; 1989 Jan; 39(1):40-4. PubMed ID: 2909912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [CSF acetylcholinesterase activity in central neurological diseases involving cholinergic systems].
    Konagaya M; Konagaya Y; Iida M
    Rinsho Shinkeigaku; 1992 Mar; 32(3):266-71. PubMed ID: 1628449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low lumbar CSF levels of homovanillic acid and 5-hydroxyindoleacetic acid in multiple system atrophy with autonomic failure.
    Polinsky RJ; Brown RT; Burns RS; Harvey-White J; Kopin IJ
    J Neurol Neurosurg Psychiatry; 1988 Jul; 51(7):914-9. PubMed ID: 2462617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic autonomic failure: CSF and plasma 3-methoxy-4-hydroxyphenylglycol.
    Polinsky RJ; Jimerson DC; Kopin IJ
    Neurology; 1984 Jul; 34(7):979-83. PubMed ID: 6539879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody in the CSF of patients with multiple system atrophy reacts specifically with rat locus ceruleus.
    Polinsky RJ; McRae A; Baser SM; Dahlström A
    J Neurol Sci; 1991 Nov; 106(1):96-104. PubMed ID: 1779245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Migraine: a chronic sympathetic nervous system disorder.
    Peroutka SJ
    Headache; 2004 Jan; 44(1):53-64. PubMed ID: 14979884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of anti-locus coeruleus immunoreactivity in CSF of patients with autonomic failure.
    Imrich R; Goldstein DS; Jacobowitz DM
    Clin Auton Res; 2006 Dec; 16(6):401-5. PubMed ID: 16977375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance P in human cerebrospinal fluid: reductions in peripheral neuropathy and autonomic dysfunction.
    Nutt JG; Mrox EA; Leeman SE; Williams AC; Engel WK; Chase TN
    Neurology; 1980 Dec; 30(12):1280-5. PubMed ID: 6161319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.
    Brooks DJ; Salmon EP; Mathias CJ; Quinn N; Leenders KL; Bannister R; Marsden CD; Frackowiak RS
    Brain; 1990 Oct; 113 ( Pt 5)():1539-52. PubMed ID: 2123119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid levels of acetylcholinesterase, monoamines and oxytocin during labour, parturition, vaginocervical stimulation, lamb separation and suckling in sheep.
    Kendrick KM; Keverne EB; Baldwin BA; Sharman DF
    Neuroendocrinology; 1986; 44(2):149-56. PubMed ID: 3796790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acetylcholinesterase activity in CSF in senile dementia of Alzheimer type, vascular dementia, and Parkinson's disease].
    Yoshinaga J; Sasaki T; Ideshita H; Hikiji A; Kuwaki T
    Rinsho Shinkeigaku; 1989 Mar; 29(3):376-8. PubMed ID: 2752667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral neuropathy in multiple system atrophy with autonomic failure.
    Galassi G; Nemni R; Baraldi A; Gibertoni M; Colombo A
    Neurology; 1982 Oct; 32(10):1116-21. PubMed ID: 6289187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of autonomic dysfunction to CSF concentrations of noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's disease.
    Turkka JT; Juujärvi KK; Myllylä VV
    Eur Neurol; 1987; 26(1):29-34. PubMed ID: 3816883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. REM sleep behaviour disorder differentiates pure autonomic failure from multiple system atrophy with autonomic failure.
    Plazzi G; Cortelli P; Montagna P; De Monte A; Corsini R; Contin M; Provini F; Pierangeli G; Lugaresi E
    J Neurol Neurosurg Psychiatry; 1998 May; 64(5):683-5. PubMed ID: 9598693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central and peripheral effects of arecoline in patients with autonomic failure.
    Polinsky RJ; Brown RT; Curras MT; Baser SM; Baucom CE; Hooper DR; Marini AM
    J Neurol Neurosurg Psychiatry; 1991 Sep; 54(9):807-12. PubMed ID: 1659617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuropathological background of spinocerebellar degeneration--with special reference to autonomic nervous system lesions in olivopontocerebellar atrophy, Shy-Drager syndrome and multiple system atrophy].
    Mizutani T
    No To Shinkei; 1985 Jul; 37(7):675-85. PubMed ID: 4063122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems.
    Ruberg M; Villageois A; Bonnet AM; Pillon B; Rieger F; Agid Y
    J Neurol Neurosurg Psychiatry; 1987 May; 50(5):538-43. PubMed ID: 2953866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subarachnoid block for a case of multiple system atrophy.
    McBeth C; Murrin K
    Anaesthesia; 1997 Sep; 52(9):889-92. PubMed ID: 9349073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal intranuclear hyaline inclusion disease showing motor-sensory and autonomic neuropathy.
    Sone J; Hishikawa N; Koike H; Hattori N; Hirayama M; Nagamatsu M; Yamamoto M; Tanaka F; Yoshida M; Hashizume Y; Imamura H; Yamada E; Sobue G
    Neurology; 2005 Nov; 65(10):1538-43. PubMed ID: 16301479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.